Related Experiment Video

Updated: Jul 10, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

[A life-threatening cardiomyopathy following port-a-cath infection under immune tolerance therapy]

G Wiegand1, R Rauch, M Girisch

  • 1Abteilung Kinderkardiologie und pädiatrische Intensivmedizin, Universitätsklinikum Tübingen, Klinik für Kinder- und Jugendmedizin, Hoppe-Seyler-Str. 1, 72076 Tübingen. gesa.wiegand@med.uni-tuebingen.de

Hamostaseologie
|October 17, 2007
PubMed

Insights

Severe hemophilia A patients on immune tolerance therapy (ITT) face risks from central venous access devices, including fatal cardiac complications. Early cardiac evaluation is crucial for those with inhibitors and cardiomyopathy.

Area of Science:

  • Hematology
  • Cardiology
  • Immunology

Background:

  • Severe hemophilia A necessitates immune tolerance therapy (ITT) to manage factor VIII inhibitors.
  • ITT often requires indwelling central venous catheters, posing risks of thrombosis and infection.

Observation:

  • A case report of an 18-year-old male with severe hemophilia A and a high-titer factor VIII inhibitor.
  • The patient developed severe sepsis and congestive cardiac failure post-port catheter implantation for ITT.
  • Dilated cardiomyopathy, congestive heart failure, and fatal ventricular arrhythmias ensued, leading to ITT cessation.

Findings:

  • Central venous access for ITT in hemophilia A patients with inhibitors can lead to severe systemic complications.
  • Dilated cardiomyopathy is a potential, life-threatening complication in this patient population.
  • Early assessment for cardiac transplantation should be considered in hemophilia A patients with inhibitors and cardiomyopathy.

Implications:

  • Highlights the critical need for vigilant cardiac monitoring in hemophilia A patients undergoing ITT.
  • Suggests a multidisciplinary approach involving hematologists and cardiologists for optimal patient management.
  • Emphasizes the importance of considering alternative therapies or early interventions to mitigate risks associated with ITT complications.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...